Zoetis Inc. (ZTS)

NYQ – Цена в реальном времени. Валюта: USD

72.39

-2.96 (-3.93%)

Рынок открыт: Aug 12, 2026, 11:56 AM EDT

75.39

+0.04 (0.05%)

Предыдущая сессия: Aug 11, 2026, 7:57 PM EDT

11.08.2026

Diamond Hill Mid Cap Fund Q2 2026 Contributors And Detractors

Equity markets posted strong returns during the second quarter, with robust corporate earnings and a resilient domestic economy supporting investor sentiment. Key contributors were Humana, Regal Rexnord, and Illumina. Key detractors were Huntington Ingalls, Wix.com, and Zoetis.

09.08.2026

Zoetis Q2 Earnings Call Highlights

Zoetis NYSE: ZTS reported second-quarter revenue of $2.5 billion, flat on a reported basis and down 1% organically, as pressure in U.S. companion-animal categories offset growth in livestock, diagnostics and international markets. Adjusted net income was $781 million, down 2% organically, while adjusted diluted earnings per share rose 4% to $1.87, benefiting from a lower share count following share repurchases.

09.08.2026

Top 50 High-Quality Dividend Growth Stocks For August 2026

I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. The universe delivered a 10.44% YTD return through July, closely matching SPY but trailing SCHD, with several individual stocks significantly outperforming. Currently, 40 stocks in the universe offer a forward return estimate of at least 10%, with 25 appearing potentially undervalued based on free cash flow analysis.

07.08.2026

ZTS Q2 Earnings Call Flags Deeper Companion Animal Pressure

Zoetis cuts its 2026 outlook as weaker vet traffic, price sensitivity and competition pressure in Companion Animal, while promotions aim to defend share.

06.08.2026

Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate Headwinds

Zoetis Inc. (NYSE:ZTS) reported second-quarter adjusted earnings of $1.87 per share, beating the consensus of $1.86.

06.08.2026

Zoetis Inc. (ZTS) Q2 2026 Earnings Call Transcript

06.08.2026

Zoetis Q2 Earnings Beat Estimates, Revenues Miss, 2026 View Cut

ZTS beats Q2 earnings estimates but misses the same for revenues. The company cuts its 2026 revenue and profit outlook.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
ZTS	William Blair	Market Perform	undefined >> undefined	August 6th 2026

Пресс-релизы

06.08.2026

Zoetis Announces Second Quarter 2026 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the second quarter of 2026. The company reported revenue of $2.5 billion for the second quarter of 2026, flat compared with the second quarter of 2025, decreasing 1% on an organic operational1 basis. Net income for the second quarter of 2026 was $691 million, or $1.65 per diluted share, decreasing 5% and growing 1%, respectively, on a reported basis. Adj.

06.08.2026

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In this newly created role, Mr. Saccaro will lead Zoetis' global finance function, shaping capital allocation, financial strategy, reporting and controls, and investor engagement and oversee Global Manufacturing and Supply to drive operational execution and performance. With.

Zoetis Inc. (ZTS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Zoetis Inc. (ZTS)